197 related articles for article (PubMed ID: 31023021)
1. Possible Usage of p63 in Bioptic Diagnostics.
Galoczová M; Nenutil R; Coates P; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
3. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Alkhayyat R; Abbas A; Quinn CM; Rakha EA
Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
[TBL] [Abstract][Full Text] [Related]
4. [Application of PLA Method for Detection of p53/p63/p73 Complexes in Situ in Tumour Cells and Tumour Tissue].
Hrabal V; Nekulová M; Nenutil R; Holčaková J; Coates PJ; Vojtěšek B
Klin Onkol; 2017; 30(Supplementum1):159-162. PubMed ID: 28471195
[TBL] [Abstract][Full Text] [Related]
5. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
6. The Role of HSF1 Protein in Malignant Transformation.
Šimončík O; Pastorek M; Vojtěšek B; Müller P
Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
[TBL] [Abstract][Full Text] [Related]
7. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
9. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
10. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
11. HDM2 and HDMX Proteins in Human Cancer.
Hároníková L; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026
[TBL] [Abstract][Full Text] [Related]
12. Expression and Functional Characterization of miR-34c in Cervical Cancer.
Sommerová L; Fraňková H; Anton M; Jandáková E; Vojtěšek B; Hrstka R
Klin Onkol; 2018; 31(Suppl 2):82-87. PubMed ID: 31023029
[TBL] [Abstract][Full Text] [Related]
13. Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?
Sailer V; Stephan C; Wernert N; Perner S; Jung K; Dietel M; Kristiansen G
Histopathology; 2013 Jul; 63(1):50-6. PubMed ID: 23668398
[TBL] [Abstract][Full Text] [Related]
14. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
[TBL] [Abstract][Full Text] [Related]
15. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas.
Liszka Ł
Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306
[TBL] [Abstract][Full Text] [Related]
16. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study.
Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L
Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022
[TBL] [Abstract][Full Text] [Related]
17. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
Khazai L; Agosto-Arroyo E; Rosa M
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
[TBL] [Abstract][Full Text] [Related]
18. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
19. Prima-1 and APR-246 in Cancer Therapy.
Zatloukalová P; Galoczová M; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):71-76. PubMed ID: 31023027
[TBL] [Abstract][Full Text] [Related]
20. Benign and malignant odontogenic neoplasms of the jaws show a concordant nondiscriminatory p63/p40 positive immunophenotype.
Argyris PP; Malz C; Taleb R; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):506-512. PubMed ID: 30309829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
